IFNA1 and bacterial infectious disease with sepsis: Recombinant IFN-ɣ has been shown to be beneficial in the treatment of cryptococcal meningitis [26] and other fungal infections [27], and a trial to investigate its application for bacterial sepsis is ongoing [28].